Tabuk’s Pharmacovigilance System and Risk Management Plans are the first system accepted by JFDA for a generic company in Jordan. It is the most advanced system presented to the Health Authorities by a generic Pharmaceutical Company. Risk Management Planning with all related Standard Operating Procedures and Periodic safety update reports were all started in Jordan since mid of 2008.
Internationally, Tabuk Poland Sp.o o successfully registered in the European EudraVigilance via EV-web. (This allows the direct communication and connection with European Health Authorities for Pharmacovigilance data handling).
This registration is essential for the practical implementation of the Pharmacovigilance system in the various European countries (taking care about safety concerns).